Interleukin-27 and interleukin-23 modulate human plasmacell functions

Journal of Leukocyte Biology

Volumn 89, Issue 5, 2011, Pages 729-734

  Cocco, Claudia ^a   Morandi, Fabio ^b   Airoldi, Irma ^b  

^a Department of Experimental Medicine   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

B lymphocytes; Cytokine receptors; Cytokines

Indexed keywords

CHEMOKINE RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 23; INTERLEUKIN 27;

ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

B-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINES; CHEMOTAXIS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-17; INTERLEUKIN-23; PLASMA CELLS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 79955844662     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1210660     Document Type: Article

References (19)

1. Trinchieri, G., Pflanz, S., Kastelein, R. A. (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641-644.
2. Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M. H., Gurney, A., Grewal, I. S., de Sauvage, F. J. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407, 916-920.
3. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., Kastelein, R. A. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231.
4. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., To, W., Wagner, J., O'Farrell, A. M., McClanahan, T., Zurawski, S., Hannum, C., Gorman, D., Rennick, D. M., Kastelein, R. A., de Waal Malefyt, R., Moore, K. W. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708.
5. Larousserie, F., Charlot, P., Bardel, E., Froger, J., Kastelein, R. A., Devergne, O. (2006) Differential effects of IL-27 on human B cell subsets. J. Immunol. 176, 5890-5897.
6. Boumendjel, A., Tawk, L., Malefijt Rde, W., Boulay, V., Yssel, H., Pene, J. (2006) IL-27 induces the production of IgG1 by human B cells. Eur. Cytokine Netw. 17, 281-289.
7. Medina, F., Segundo, C., Campos-Caro, A., Gonzalez-Garcia, I., Brieva, J. A. (2002) The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99, 2154-2161.
8. Tarte, K., De Vos, J., Thykjaer, T., Zhan, F., Fiol, G., Costes, V., Reme, T., Legouffe, E., Rossi, J. F., Shaughnessy Jr., J., Orntoft, T. F., Klein, B. (2002) Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood 100, 1113-1122.
9. Airoldi, I., Cocco, C., Giuliani, N., Ferrarini, M., Colla, S., Ognio, E., Taverniti, G., Di Carlo, E., Cutrona, G., Perfetti, V., Rizzoli, V., Ribatti, D., Pistoia, V. (2008) Constitutive expression of IL-12R β 2 on human multiple myeloma cells delineates a novel therapeutic target. Blood 112, 750-759.
10. Lucas, S., Ghilardi, N., Li, J., de Sauvage, F. J. (2003) IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100, 15047-15052.
11. Klein, U., Tu, Y., Stolovitzky, G. A., Keller, J. L., Haddad Jr., J., Miljkovic, V., Cattoretti, G., Califano, A., Dalla-Favera, R. (2003) Transcriptional analysis of the B cell germinal center reaction. Proc. Natl. Acad. Sci. USA 100, 2639-2644.
12. Calame, K. L. (2001) Plasma cells: finding new light at the end of B cell development. Nat. Immunol. 2, 1103-1108.
13. Yen, J. H., Kong, W., Ganea, D. (2010) IFN-β inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J. Immunol. 184, 3478-3486.
14. Airoldi, I., Di Carlo, E., Banelli, B., Moserle, L., Cocco, C., Pezzolo, A., Sorrentino, C., Rossi, E., Romani, M., Amadori, A., Pistoia, V. (2004) The IL-12R2 gene functions as a tumor suppressor in human B cell malignancies. J. Clin. Invest. 113, 1651-1659.
15. Kanegane, C., Sgadari, C., Kanegane, H., Teruya-Feldstein, J., Yao, L., Gupta, G., Farber, J. M., Liao, F., Liu, L., Tosato, G. (1998) Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J. Leukoc. Biol. 64, 384-392.
16. Mahalingam, S., Chaudhri, G., Tan, C. L., John, A., Foster, P. S., Karupiah, G. (2001) Transcription of the interferon γ (IFN-γ)-inducible chemokine Mig in IFN- -deficient mice. J. Biol. Chem. 276, 7568-7574.
17. Farber, J. M. (1997) Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61, 246-257.
18. Romagnani, S. (2002) Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38, 881-885.
19. Tarte, K., Zhan, F., De Vos, J., Klein, B., Shaughnessy Jr., J. (2003) Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood 102, 592-600.